Pulmonary toxicity of bischloronitrosourea:Report of a case with transient response to corticosteroid therapy
- 1 May 1979
- Vol. 43 (5) , 1607-1612
- https://doi.org/10.1002/1097-0142(197905)43:5<1607::aid-cncr2820430507>3.0.co;2-0
Abstract
A case of interstitial pulmonary fibrosis secondary to bischloronitrosourea (BCNU) in a 49-year-old man with carcinoma of the pancreas is reported. The diagnosis was suggested by deteriorating oxygenation, restrictive changes on pulmonary function studies, and increased interstitial markings radiographically in the lower lung fields. Transbronchial biopsy excluded infectious etiologies and confirmed a bland nonspecific interstitial pulmonary fibrosis of recent origin. The patient responded dramatically to high dose corticosteroids, but relapsed when the corticosteroids were decreased. We believe there is now convincing evidence that prolonged use of BCNU can cause potentially fatal interstitial pulmonary fibrosis. Patients should be followed with serial chest radiographs and pulmonary function studies. If diagnosed early, this process may respond to high dose corticosteroid therapy.This publication has 5 references indexed in Scilit:
- Cytotoxic drug-induced lung diseaseThe American Journal of Medicine, 1977
- PULMONARY TOXICITY IN LONG-TERM ADMINISTRATION OF BCNU1976
- Pulmonary Allergic Granulomatosis: A Possible Drug Reaction in a Patient Receiving Cromolyn SodiumChest, 1974
- The Spectrum of Drug-Induced Pulmonary DiseaseAnnals of Internal Medicine, 1972
- Central nervous system leukemia and solid tumors of childhood:Treatment with 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU)Cancer, 1966